GlassScriptPhysician profile
Joseph J Wallis
NPI 1285672154
$830.24
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $193 · 2022: $51.67 · 2023: $4.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $362.00 | 2019-2020 | |
| Therapeuticsmd, INC. | $151.59 | 2019-2022 | |
| Abbvie INC. | $67.02 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $63.85 | 2019-2020 | |
| Exeltis, USA INC. | $57.64 | 2019-2020 | |
| Avion Pharmaceuticals | $26.79 | 2019-2020 | |
| Amgen INC. | $15.00 | 2019 | |
| Myovant Sciences INC. | $15.00 | 2022 | |
| Duchesnay USA Incorporated | $14.59 | 2019 | |
| Daiichi Sankyo INC. | $13.93 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.69 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.33 | 2019 | |
| Millicent US INC | $10.93 | 2019 | |
| Mayne Pharma Commercial LLC | $4.88 | 2023 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Wallis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.